Project Grant K23DK138324
Award Date
8/1/24
Completion Date
5/31/29
Dollars Obligated
$393K
Similar Awards
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research to investigate the real-time impacts of psychosocial factors on blood glucose levels among adults with type 1 diabetes. The $211,590 award to Carnegie Mellon University will fund a 20-month study combining ecological momentary assessments and continuous glucose...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will provide $575,394 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop a multi-ancestry polygenic risk score for type 1 diabetes (T1D) and related immune-mediated conditions. The project aims to improve genetic risk prediction for T1D across...
This $1,506,686 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will fund a pragmatic, clinic-based trial of a mindfulness-based intervention for mood concerns in youth with type 1 diabetes. The primary goal is to evaluate the efficacy of the "BREATHE-T1D" intervention compared to an educational control condition ("HEALTHED-T1D") across two clinical sites...
This $1,338,684 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports a longitudinal study to utilize PET and MRI techniques to assess insulin vesicle functional capacity, beta cell mass, and pancreas volume in individuals at risk for and with recent onset type 1 diabetes. The goal is to provide a comprehensive picture of multiple measures of...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to identify how daily partner health behaviors and communal coping strategies relate to glycemic control among emerging adult couples with type 1 diabetes (T1D). The total award amount is $419,750 over a 3-year period from March 2025 to February 2028. The award recipient is Brigham Young...
This federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to investigate the cardiometabolic benefits of reducing iatrogenic hyperinsulinemia in individuals with type 1 diabetes (T1DM) through the use of insulin adjunctive therapy. The $340,747 award, with a start date of September 1, 2024 and an ultimate completion date of July 31,...
This Project Grant award for $749,566 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support research to evaluate the impact of the Inflation Reduction Act (IRA) on insulin affordability and health outcomes for Medicare beneficiaries with diabetes. The research will leverage claims data from the OptumLabs Data Warehouse and Medicare Fee-for-Service to compare...
This Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to test the feasibility and preliminary efficacy of a personalized intervention called T1CARE. T1CARE involves a comprehensive assessment of social and clinical needs for young adults with type 1 diabetes, coupled with a hybrid community health worker-patient navigator approach to...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research at the Joslin Diabetes Center to investigate the impact of glucose toxicity on beta-cell function and translational regulation. The $2,155,558 award, spanning from Aug 2, 2024 to May 31, 2027, will test the hypothesis that glucose toxicity leads to dysregulation of...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $167,864 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct a mixed methods study on developing a diabetes self-management education and support (DSMES) intervention for people with type 2 diabetes experiencing food insecurity. The research aims to:...